SEC Form 4 · accession 0001171843-17-005069
Xenon Pharmaceuticals Inc. · XENE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Simon N. Pimstone
Officer — President & CEO · Director
Period of report
Aug 10, 2017
Accepted (ET)
Aug 14, 2017 · 6:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001582313
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Aug 10, 2017 | P | 6,000 | $2.90 | A | 217,847 | D | |
| Common Shares | holding | — | — | — | 16,460 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.